|
|
|
LifeScienceHistory.com - Check us out on Instagram
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Targazyme, Inc.
| | | Phone: | (760) 448-1168 | Year Established: | 2005 | Main Contact: | Bernard Cambou, Ph.D., MBA, CBO | | Other Contacts: | Hubert Tseng, Ph.D., Senior Translational Scientist Officer Shah Rahimian, M.D, VP, Clinical Development & Regulatory Affairs Richard Martin, Ph.D., VP of CMC and Head of Operations Audrey Jakubowski, Ph.D., Senior VP, Regulatory Affairs & Quality Assurance Stephen D. Wolpe, Ph.D., CSO Lynnet Koh, M.B.A., Chairman, CEO & Founder
| | Company Description | Targazyme, formerly America Stem Cell, is a clinical-stage biopharmaceutical company developing and commercializing breakthrough products designed to improve outcomes for patients receiving cell therapy. Targazyme’s platform technologies improve the clinical efficacy of therapeutic cells by directing their migration to sites of inflammation, ischemia and/or tissue damage in the body, as well as by improving retention in those tissues. By directing these cells to where they are most needed, Targazyme’s technologies can improve the effectiveness of therapeutic cells in numerous disease indications. | |
|
|
|
|
|